Chester County News and Community Website
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved blinatumomab (Blincyto, Amgen Inc.) for both adult and pediatric patients one month and older with CD19-positive Philadelphia chromosome-negative …
FDA Approves Blinatumomab for Advanced Leukemia Treatment Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), along with The White House, has recently unveiled …
U.S. Government Rolls Out National Strategy to Halve Food Waste by 2030 Read More
MALVERN, PA — Almirall announced that the U.S. Food and Drug Administration (FDA) recently approved an expansion for its drug Klisyri, allowing it to be used over a larger surface …
FDA Approves Expanded Use for Almirall’s Klisyri in Actinic Keratosis Treatment Read More
WASHINGTON, D.C. — On Friday, the U.S. Food and Drug Administration proposed an exemption for certain cottage cheese products from the Food Traceability Rule. This rule mandates extra recordkeeping for …
FDA Proposes Exemption for Cottage Cheese from Traceability Rules Read More
WASHINGTON, D.C. — On Friday, the FDA announced a recall initiated by Merit Medical Systems, Inc. after Jiangsu Shenli Medical Production Co Ltd. issued a recall for its unauthorized plastic …
FDA Announces Recall of Unauthorized Plastic Syringes Read More
WASHINGTON, D.C. — On Thursday, the FDA issued warning letters to six online retailers for selling unauthorized e-liquid products from the Bad Drip brand, which mimic prescription drug bottles. The …
FDA Cracks Down on Retailers Selling Unauthorized E-Liquids and E-Cigarettes Read More
WASHINGTON, D.C. — On Thursday, the Food and Drug Administration granted accelerated approval to repotrectinib (AUGTYRO), a new drug for treating certain advanced solid tumors in patients aged 12 and …
FDA Grants Accelerated Approval for New Cancer Drug Repotrectinib Read More
WASHINGTON, D.C. — The FDA on Wednesday granted full approval to the drug selpercatinib, marketed as Retevmo, for treating advanced thyroid cancer in both adults and children aged 2 and …
FDA Grants Full Approval to Retevmo for Advanced Thyroid Cancer Read More
WASHINGTON, D.C. — On Tuesday, the FDA issued warning letters to four companies marketing the unapproved animal drug toltrazuril. The companies involved are All Things Bunnies Inc., Linessa Farms LLC, …
FDA Issues Warning Letters to Companies Selling Unapproved Animal Drug Read More
WASHINGTON, D.C. — The FDA on Tuesday approved phenylpropanolamine hydrochloride chewable tablets for the control of urinary incontinence in dogs. This is the first generic version of these tablets, which …
FDA Approves Generic Chewable Tablets for Dog Incontinence Read More